Albireo Pharma, Inc. Made Headway
Mon, Jan 09, 2023 at 07:02 PM
Albireo Pharma, Inc. (ALBO:NASDAQ) jumped higher at $43.85, representing a gain of 92.2%. On Mon, Jan 09, 2023, ALBO:NASDAQ hit a New 2-Week High of $43.85. The stock got featured on our News Catalysts scanner on Mon, Jan 09, 2023 at 02:14 PM in the 'ACQUISITION' category. From Tue, Dec 27, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days
About Albireo Pharma, Inc. (ALBO:NASDAQ)
Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.
Top 10 Gainers:
- CinCor Pharma Inc. (CINC:NASDAQ), 143.97%
- Amryt Pharma plc (AMYT:NASDAQ), 106.99%
- Albireo Pharma, Inc. (ALBO:NASDAQ), 92.16%
- Apexigen Inc Com (APGN:NASDAQ), 91.49%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 54.34%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 52.86%
- Duck Creek Technologies Inc. (DCT:NASDAQ), 46.5%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 42.39%
- Ebang International Holdings Inc. (EBON:NASDAQ), 40.72%
- Greenidge Generation Holdings Inc. (GREE:NASDAQ), 37.9%